FDA warns retailers against illegal sale of e-cigarettes to children
The Food and Drug Administration issued warnings to 40 retail and online stores as part of a month-long operation against illegal sales of Juul to children. Investigators targeted 7-Eleven locations, Shell gas stations and Cumberland Farms convenience stores as well…
Marijuana-based drug gets positive review from FDA
The Food and Drug Administration posted its review Tuesday of the experimental medication ahead of a public meeting later this week.
Physicians, ethicists urge Congress not to pass ‘right-to-try’ legislation
Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health.
How a government shutdown could affect your health
A government shutdown of the FDA, CDC and NIH will likely have widespread and long-lasting consequences for public health.
A wearable device claiming to block the pain of opioid withdrawal has been cleared by the Food and Drug Administration under a new expedited review process.
Patients can track their dosage on their smartphone and allow their doctors or caregivers to access the information through a website.
As the first gene therapies approach the market, drug makers, insurers, and patients are debating complex questions about cost, value, and payment plans.
The Senate Health, Education, Labor and Pensions Committee is scheduled to convene at 10 a.m. ET to discuss how well the federal government has responded to a mounting public health crisis over opioids.
The Food and Drug Administration has asked Endo Pharmaceuticals to withdraw its Opana ER painkiller over concerns that the drug is too easily abused, the first time the agency has made such a move.
